ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baker, R. R.
Right arrow Articles by Marsh, B. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baker, R. R.
Right arrow Articles by Marsh, B. R.

Ann Thorac Surg 1975;20:520-528
© 1975 The Society of Thoracic Surgeons


Articles

The Clinical Assessment of Selected Patients with Bronchogenic Carcinoma

R. Robinson Baker, M.D.*, Frederick P. Stitik, M.D., Bernard R. Marsh, M.D.

Departments of Surgery, Radiology, and Otolaryngology, The Johns Hopkins University School of Medicine, Baltimore, Md.

* Address reprint requests to Dr. Baker, Department of Surgery, The Johns Hopkins Hospital, 601 N. Broadway, Baltimore, Md. 21205

This paper describes the clinical management of patients with malignant cells in their sputum and a normal chest roentgenogram and those with asymptomatic peripheral pulmonary masses. The source of malignant cells in the sputum of patients with no roentgenographic abnormalities can be localized by tantalum bronchography and fiberoptic bronchoscopy. Peripheral pulmonary masses can be diagnosed preoperatively by needle biopsy or trans-bronchial fiberoptic bronchoscopy with little morbidity and no mortality. These procedures are not necessary, however, if there is firm clinical and roentgenographic evidence of malignancy. Bronchogenic carcinomas presenting as asymptomatic circumscribed peripheral pulmonary masses have a 25% incidence of occult mediastinal lymph node metastases. In view of this relatively high incidence of metastasis, we think mediastinoscopy should routinely be performed prior to thoracotomy in asymptomatic patients with a peripheral pulmonary mass and no roentgenographic evidence of mediastinal widening.




This article has been cited by other articles:


Home page
ChestHome page
G. Schreiber and D. C. McCrory
Performance Characteristics of Different Modalities for Diagnosis of Suspected Lung Cancer: Summary of Published Evidence
Chest, January 1, 2003; 123(2009): 115S - 128S.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
Y. Lacasse, E. Wong, G. H Guyatt, and D. J Cook
Transthoracic needle aspiration biopsy for the diagnosis of localised pulmonary lesions: a meta-analysis
Thorax, October 1, 1999; 54(10): 884 - 893.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1975 by The Society of Thoracic Surgeons.